Cannabix Technologies, Inc.

  • Market Cap: N/A
  • Industry: Minerals & Mining
  • ISIN: CA13765L1013
CAD
0.52
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

12.5 k

Shareholding (Apr 2021)

FII

0.13%

Held by 7 FIIs

DII

99.87%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Minerals & Mining

stock-summary
Market cap

CAD 61 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.85

stock-summary
Return on Equity

-258.93%

stock-summary
Price to Book

26.79

Revenue and Profits:
Net Sales:
(Quarterly Results - Apr 2025)
Net Profit:
-3 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-7.14%
0%
-7.14%
6 Months
-8.77%
0%
-8.77%
1 Year
28.4%
0%
28.4%
2 Years
141.86%
0%
141.86%
3 Years
-8.77%
0%
-8.77%
4 Years
-8.77%
0%
-8.77%
5 Years
-40.91%
0%
-40.91%

Cannabix Technologies, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
-24.21%
EBIT to Interest (avg)
-3.39
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
26.28
EV to EBIT
-9.74
EV to EBITDA
-10.02
EV to Capital Employed
57.93
EV to Sales
NA
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-594.74%
ROE (Latest)
-258.93%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Apr 2021stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 7 Foreign Institutions (0.13%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Apr 2025 is -108.33% vs -300.00% in Apr 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Apr'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-2.50",
          "val2": "-1.20",
          "chgp": "-108.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.50",
          "val2": "-1.20",
          "chgp": "-108.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Apr'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Apr 2024 is 0.00% vs 0.00% in Apr 2023",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Apr 2024 is -47.62% vs 38.24% in Apr 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Apr'24",
        "Apr'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.10",
          "val2": "-2.20",
          "chgp": "-40.91%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-3.10",
          "val2": "-2.10",
          "chgp": "-47.62%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Apr'25 - YoYstock-summary
Apr'25
Apr'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-2.50
-1.20
-108.33%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-2.50
-1.20
-108.33%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Apr 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Apr 2025 is -108.33% vs -300.00% in Apr 2024

Annual Results Snapshot (Consolidated) - Apr'24stock-summary
Apr'24
Apr'23
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-3.10
-2.20
-40.91%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-3.10
-2.10
-47.62%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales

YoY Growth in year ended Apr 2024 is 0.00% vs 0.00% in Apr 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Apr 2024 is -47.62% vs 38.24% in Apr 2023

stock-summaryCompany CV
About Cannabix Technologies, Inc. stock-summary
stock-summary
Cannabix Technologies, Inc.
Minerals & Mining
Cannabix Technologies Inc is a Canada-based company, which is engaged in Marijuana Breathalyzer development for law enforcement and the workplace. The Company is developing breath testing technologies in the pursuit of bringing durable, portable hand-held tools to the market to enhance detection of marijuana impaired driving offences on roads. The Company offers Beta 2.0 Cannabix Marijuana Breathalyzer. The Company is developing drug-testing devices that detect the psychoactive component (THC) of marijuana that causes intoxication-using breath samples. The Company also develops breath-testing devices for detection of use of THC, in contrast to urine testing for THC metabolite that requires an invasive collection and reflects use days or even weeks earlier. The Company's breath-testing devices are also useful for other practical applications, such as testing employees in the workplace where intoxication by THC can be hazardous.
Company Coordinates stock-summary
Company Details
501-3292 Production Way , BURNABY BC : V5A 4R4
Registrar Details